How many institutions held CLDI - Calidi Biotherapeutics, Inc. - Common Stock, $0.0001 par value in Q3 2025?

21 institutional investors reported CLDI - Calidi Biotherapeutics, Inc. - Common Stock, $0.0001 par value for Q3 2025. Use the holders table for investor-level position and value details.

Calidi Biotherapeutics, Inc. - Common Stock, $0.0001 par value (CLDI)

Q: What does CUSIP 320703408 represent in this 13F holders report?

CUSIP 320703408 is the security identifier for CLDI - Calidi Biotherapeutics, Inc. - Common Stock, $0.0001 par value used to aggregate holder disclosures.

CUSIP: 320703408

Q3 2025 13F Holders as of 30 Sep 2025

Security type / class: Equity / Common Stock, $0.0001 par value
Total 13F shares: 211,031
Total 13F value: $320,773
Share change: +211,031
SEC-reported price per share: $1.52
Number of holders: 21
Value change: +$320,773
Number of buys: 21
Shares outstanding: 7,142,857

Security key

320703408

Report period

Q3 2025

Institutions

Top holders

CLDI full security history Ownership snapshot Full 13F holder table Newer quarter: Q4 2025 Calidi Biotherapeutics, Inc. SEC filings Calidi Biotherapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 320703408

Newer quarter: Q4 2025

Recent filing periods:

Q3 2026 Q2 2026 Q1 2026 Q4 2025 Q3 2025

Ownership snapshot

Top reported holders of CLDI - Calidi Biotherapeutics, Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

ARMISTICE CAPITAL, LLC

Disclosed value leader

Polar Asset Management Pa...

Comparable rows

1/15

Latest evidence

20 Aug 2025

13F 13D/G 3/4/5 Lead comparable stake: 5% 14 rows are not safely comparable across share classes. 13D/G row: ARMISTICE CAPITAL, LLC Showing 1-6 of 15 holder rows.

Quick read

ARMISTICE CAPITAL, LLC leads the comparable SEC ownership view at 5%.

1 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ARMISTICE CAPITAL, LLC's linked filing trail.

Comparable ownership Top 1

ARMISTICE CAPITAL, LLC 5%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
ARMISTICE CAPITAL, LLC	13F 13D/G Company 13F 13D/G	5% Reported 13D/G · 30 Jun 2025	$182,160 792,000 shares	—	30 Jun 2025
Polar Asset Management Partners Inc.	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$4,330,272 412,800 shares	—	19 Oct 2022
Lincoln Alternative Strategies LLC	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$430,700 730,000 shares	—	20 Aug 2025
First Light Acquisition Group, LLC	3/4/5 10%+ Owner 3/4/5	— denominator unverified	— 1,931,852 shares	—	16 Jun 2023
Stephen Thesing	3/4/5 Chief Business Officer 3/4/5	— denominator unverified	$848,779 471,544 shares	—	12 Sep 2023
Boris Radoslavov Minev	3/4/5 Interim Chief Medical Officer 3/4/5	— mixed-class rows	$764,024 455,818 shares mixed-class rows	—	17 Jun 2024

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

211,031

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2025 vs Q2 2026 Across Filers

Q2 2026 holders

Q3 2025 holders

Holder diff

-1

Investor	Q2 2026 Shares	Q3 2025 Shares	Share Diff	Share Chg %	Q2 2026 value	Q3 2025 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend